2017.11.29

The 2nd JGOG-KGOG Young Doctor's Meeting

 

 

HIdeaki Tsuyoshi

「ＡMulti-centter,Open-label,Randomized,Two-arm PhaseⅡ/Ⅲ Trial of the Effect on Progression Free Survival of Bevacizumab Plus Olaparib Versus Bevacizumab Plus Chemotherapy in Patients With Platinum-resistant,Epithelial Ovarian,Fallopian Tube or Primary Peritoneal Cancer」

 

 

---

一覧へ